Physician profile

Eric T Anderson

Interventional Pain Medicine · Lewisville, TX

NPI 1811159973

$13,128.33

in general payments reported to CMS, 2019-2025

43 companies · $2,159 in 2025

The $2,159 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,505.05
Travel and Lodging$799.22
Consulting Fee$125.00
Gift$15.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Nevro Corp. $2,345.64 2019-2024 Senza
Spinal Simplicity, LLC $2,341.22 2021-2025 Ha Minuteman G3-R
Medtronic, INC. $1,458.23 2022-2025 Intellis Adaptivestim, Inceptiv
Abbott Laboratories $1,088.79 2019-2025 Proclaim, Eterna, Ionicrf
Boston Scientific Corporation $1,064.66 2019-2025 Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System
Genesys Orthopedics Systems, L.L.C. $1,006.25 2025 Sacroiliac Joint Fusion System
Medtronic USA, INC. $499.52 2019-2020
Abbvie INC. $362.44 2021-2024 Skyrizi, Rinvoq, Botox
Biotronik Nro, INC. $358.39 2024-2025 Prospera
Nalu Medical, INC. $336.33 2023-2025 Nalu Neurostimulation System
Vertos Medical, INC. $310.64 2021-2024 Mild Device Kit
Si-Bone, INC. $231.75 2019-2025
Forte Bio-Pharma LLC $227.10 2023-2024 Prolate, Nalocet
Stratus Medical, LLC $165.29 2023 Nimbus
Spr Therapeutics, INC $147.49 2022-2025 Sprint Pns System
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Almatica Pharma LLC $134.67 2021-2023 Gralise
Arbor Pharmaceuticals, INC. $108.57 2019-2021
Scilex Pharmaceuticals INC. $105.69 2019-2025
Painteq LLC $104.75 2024 Painteq
Novartis Pharmaceuticals Corporation $85.37 2019-2024
Takeda Pharmaceuticals U.S.A., INC. $68.26 2020-2024 Entyvio
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $57.24 2020-2021
Vertex Pharmaceuticals Incorporated $51.50 2024-2025
Ibsa Pharma INC. $49.19 2020-2021
Assertio Therapeutics, INC. $42.78 2019
Allergan, INC. $39.68 2021-2022
Globus Medical, INC. $37.17 2025 Vyrsa V1
Saluda Medical Americas, INC. $32.75 2025 Evoke
Motiva USA, LLC $28.59 2025
Depuy Synthes Sales INC. $28.29 2019
Ferring Pharmaceuticals INC. $20.59 2024 Rebyota
Fidia Pharma USA INC. $18.97 2022
Qol Medical, LLC $18.41 2021
Shire North American Group INC $17.62 2019
Epimed International, INC $16.83 2019
Azurity Pharmaceuticals, INC. $15.98 2023 Horizant
Grt US Holding, INC. $15.32 2021
Trevena, INC. $15.29 2021
Stimwave Technologies Incorporated $14.94 2022
Nestle Healthcare Nutrition INC. $14.35 2022
Aimmune Therapeutics, INC. $14.04 2024
Djo, LLC $13.98 2019
Curonix LLC $13.77 2024 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric T Anderson

$13,128.33

in general payments reported 2019-2025

Years
2019-2025
Top company
Nevro Corp.
Context
The $2,159 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/354949/eric-t-anderson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.